Molecular basis of long-term plasticity underlying addiction

Nature Reviews Neuroscience

Volumn 2, Issue 2, 2001, Pages 119-128

  Nestler, Eric J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RODENTIA;

BACTERIAL PROTEIN; CYCLIC AMP; FOSB PROTEIN, HUMAN; PROTEIN C FOS; STREET DRUG;

ADDICTION; ANIMAL; BRAIN; DENDRITE; DRUG EFFECT; GENE EXPRESSION; HUMAN; LONG TERM POTENTIATION; METABOLISM; NERVE CELL NETWORK; NERVE CELL PLASTICITY; PHYSIOLOGY; REVIEW; RNA PROCESSING;

ANIMALS; BACTERIAL PROTEINS; BEHAVIOR, ADDICTIVE; BRAIN; CYCLIC AMP; DENDRITES; GENE EXPRESSION; HUMANS; LONG-TERM POTENTIATION; NERVE NET; NEURONAL PLASTICITY; PROTO-ONCOGENE PROTEINS C-FOS; RNA PROCESSING, POST-TRANSCRIPTIONAL; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 0035260641     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/35053570     Document Type: Article

References (91)

1. Koob, G. F. & Nestler, E. J. Neurobiology of drug addiction. J. Neuropsychiat. Clin. Neurosci. 9, 482-497 (1997).
2. Wise, R. A. Drug-activation of brain reward pathways. Drug Alcohol Dependence 51, 13-22 (1998).
3. Robinson, T. E. & Berridge, K C. The psychology and neurobiology of addiction: an incentive-sensitization view. Addiction 95, S91-S117 (2000).
4. Koob, G. F., Sanna, P P. & Bloom, F. E. Neuroscience of addiction. Neuron 21, 467-476 (1998).
5. Robbins, T W. & Everitt, B. J. Neurobehavioural mechanisms of reward and motivation. Curr. Opin. Neunobiol. 6, 228-236 (1996).
6. Self, D. W. & Nestler, E. J. Relapse to drug seeking: neural and molecular mechanisms. Drug Alcohol Dependence 51, 49-60 (1998).
7. Shaham, Y, Erb, S. & Stewart, J. Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res. Rev. 33, 13-33 (2000).
8. Nestler, E. J., Hope, B. T. & Widnell, K. L. Drug addiction: a model for the molecular basis of neural plasticity. Neuron 11, 995-1006 (1993).
9. Berke J. D. & Hyman, S. E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 25, 515-532 (2000).
10. Carey, M. & Smale, S. T. Transcriptional Regulation in Eukaryotes (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 2000).
11. Nestler, E. J. & Aghajanian, G. K Molecular and cellular basis of addiction. Science 278, 58-63 (1997).
12. Shaywitz, A. J. & Greenberg, M. E. CREB: a stimulus- induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev Biochem. 68, 821-861 (1993).
13. De Cesare, D. & Sassone-Corsi, P. Transcriptional regulation by cyclic AMP-responsive factors. Prog. Nucl. Acid Res. Mol. Biol. 64, 343-369 (2000).
14. Guitart, X. et al. Regulation of CREB phosphorylation by acute and chronic morphine in the rat locus coeruleus. J. Neurochem. 5, 1168-1171 (1992).
15. Sharma, S. K., Klee, W. A. & Nirenberg, M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl Acad. Sci. USA 72, 3092-3096 (1975).
16. Terwilliger, R. Z., Beitner-Johnson, D., Sevarino, K. A., Crain, S. M. & Nestler, E. J. A general role for adaptations in G- proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548, 100-110 (1991).
17. Unterwald, E. M., Cox, B. M., Kreek, M. J., Cote, T. E. & Izenwasser, S. Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity. Synapse 15, 33-38 (1993).
18. Bond, A. & Williams, J. T. Increased probability of GABA release during withdrawal from morphine. J. Neurosci. 17, 796-803 (1997).
19. Jolas, T., Nestler, E. J. & Aghajanian, G. K. Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an upregulation of the cyclic AMP pathway. Neuroscience 95, 433-443 (2000).
20. Chakrabarti, S., Rivera, M., Yan, S. Z., Tang, W. J. & Gintzler A. R. Chronic morphine augments Gpy/Gsa stimulation of adenylyl cyclase: relevance to opioid tolerance. Mol. Pharmacol. 54, 655-662 (1998).
21. Lane-Ladd, S. B. et al. CREB (cAMP response element binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence. J. Neurosci. 17, 7890-7901 (1997).
22. Widnell, K. L., Russell, D. & Nestler, E. J. Regulation of cAMP response element binding protein in the locus coeruleus in vivo and in a locus coeruleus-like (CATH.a) cell line in vitro. Proc. Natl Acad. Sci. USA 91, 10947-10951 (1994).
23. Coven, E. et al. Cell-type specific regulation of CREB gene expression: mutational analysis of CREB promoter activity. J. Neurochem. 71, 1865-1874 (1998).
24. Chao, J. R., Ni, Y G., Chen, J. S., Rahman, Z., & Nestler E. J. Characterization of the mouse adenylyl cyclase type VIII gene promoter: activiation by cAMP. Soc. Neurosci. Abstr. 26, 125 (2000).
25. Maldonado, R. et al. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science 273, 657-659 (1996).
26. Chen, J. S. et al. Transgenic animals with inducible, targeted gene expression in brain. Mol. Pharmacol. 54, 495-503 (1998).
27. Cole, R. L., Konradi, C., Douglass, J. & Hyman, S. E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14, 813-823 (1995).
28. Turgeon, S. M., Pollack, A. E. & Fink, J. S. Enhanced CREB phosphorylation and changes in c-Fos and FRA expression in striatum accompany amphetamine sensitization. Brain Res. 749, 120-126 (1997).
29. Shaw, T. Z. et al. Upregulation of CRE-mediated transcription during naltrexone-precipitated opiate withdrawal. Soc. Neurosci. Abstr. 25, 422 (1999).
30. Carlezon, W. A. Jr et al. Regulation of cocaine reward by CREB. Science 282, 2272-2275 (1998).
31. Barrot, M., Olivier, J. D. A., Zachariou, V, Neve, R. L. & Nestler, E. J. Influence of CREB in the nucleus accumbens shell on the sensitivity to aversive and nociceptive stimuli. Soc. Neurosci. Abstr. 26, 485 (2000).
32. Self, D. W. et al. Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self- administration and relapse of cocaine-seeking behavior. J. Neurosci. 18, 1848-1859 (1998).
33. Nestler, E. J. Genes and addiction. Nature Genet 26, 277-281 (2000).
34. Hyman, S. E. Addiction to cocaine and amphetamine. Neuron 16, 901-904 (1996).
35. Kreek, M. J. Opiate and cocaine addictions: challenge for pharmacotherapies. Pharmacol. Biochem. Behav. 57, 551-569 (1997).
36. Shippenberg, T. S. & Rea, W. Sensitization to the behavioral effects of cocaine: modulation by dynorphin and kappa- opioid receptor agonists. Pharmacol. Biochem. Behav. 57, 449-455 (1997).
37. Daunais, J. B. & McGinty, J. F. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Mol. Brain Res. 29, 201-210 (1995).
38. Spangler, R. et al. Regulation of kappa opioid receptor mRNA in the rat brain by 'binge' pattern cocaine administration and correlation with preprodynorphin mRNA. Mol. Brain Res. 38, 71-76 (1996).
39. Morgan, J. I. & Curran, T. Immediate-early genes: ten years on. Trends Neurosci. 18, 66-67 (1995).
40. Hope, B. T. et al. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 13. 1235-1244 (1994).
41. Moratalla, R., Elibol, B., Vallj M. & Graybiel, A. M. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron 17, 147-156 (1996).
42. Kelz, M. B. & Nestler, E. J. AFosB: A molecular switch underlying long-term neural plasticity. Curr. Opin. Neurol. 13, 715-720 (2000).
43. Hiroi, N. & Graybiel, A. M. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J. Comp. Neurol. 374, 70-83 (1996).
44. Atkins, J. et al. Region-specific induction of AFosB by repeated administration of typical versus atypical antipsychotic drugs. Synapse 33, 118-128 (1999).
45. Kelz, M. B. et al. Expression of the transcription factor AFosB in the brain controls sensitivity to cocaine. Nature 401, 272-276 (1999).
46. Whisler, K., Kelz, M. B., Chen, J. S., Nestler, E. J. & Self, D. W. Effects of conditional overexpression of AFosB in nucleus accumbens on cocaine self-administration and relapse to cocaine-seeking behavior. Soc. Neurosci. Abstr. 25, 811 (1999).
47. Peakman, M.-C. et al. Inducible brain-region specific expression of Ac-Jun in transgenic mice decreases sensitivity to cocaine. Soc. Neurosci.Abstr. 26, 124 (2000).
48. Hiroi, N. et al. FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc. Natl Acad. Sci. USA 94, 10397-10402 (1997).
49. White, F. J., Hu, X.-T, Zhang, X.-F. & Wolf, M. E. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J. Pharmacol Exp. Ther. 273, 445-454 (1995).
50. O'Donovan, K. J., Tourtellotte, W. G., Millbrandt, J. & Baraban, J. M. The EGR family of transcription-regulatory factors: progress at the interface of molecular and systems neuroscience. Trends Neurosci. 22, 167-173 (1999).
51. Mackler, S. A. et al. NAC-1 is a brain POZ/BTB protein that can prevent cocaine-induced sensitization in the rat. J. Neurosci. 20, 6210-6217 (2000).
52. Piazza, P V & Le Moal, M. Glucocorticoids as a biological substrate of reward: physiological and pathophysiological implications. Brain Res. Rev. 25, 359-372 (1997).
53. Tasken, K. et al. Structure, function, and regulation of human cAMP-dependent protein kinases. Adv. Second Messenger Phosphoprotein Res. 31, 191-204 (1997).
54. Boundy, V. A., Chen, J. & Nestler, E. J. Regulation of cAMP- dependent protein kinase subunit expression in CATH.a and SH-SY5Y cells. J. Pharmacol. Exp. Ther 286, 1058-1065 (1998).
55. Lefkowitz, R. J. G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J. Biol. Chem. 273, 18677-18680 (1998).
56. Whistler, J. L., Chuang, H. H., Chu, P., Jan, L. Y. & Vonzastrow, M. Functional dissociation of mu opioid receptor signaling and endocytosis: Implications for the biology of opiate tolerance and addiction. Neuron 23, 737-746 (1999).
57. Ferguson, S. S., Zhang, J., Barak, L. S. & Caron, M. G. Molecular mechanisms of G protein-coupled receptor desensitization and resensitization. Life Sci. 62, 1561-1565 (1998).
58. Zaki, P A., Keith, D. E. Jr, Brine, G. A., Carroll, F I. & Evans, C. J. Ligand-induced changes in surface mu-opioid receptor number: relationship to G protein activation? J. Pharmacol. Exp. Ther. 292, 1127-1134 (2000).
59. Bohn, L. M. et al. Enhanced morphine analgesia in mice lacking β-arrestin-2. Science 286, 2495-2498 (1999).
60. Bohn, L. M. et al. µ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence. Nature 408, 720-723 (2000).
61. Terwilliger, R. Z., Ortiz, J., Guitart, X. & Nestler, E. J. Chronic morphine administration increases β-adrenergic receptor kinase (PARK) levels in the rat locus coeruleus. J. Neurochem. 63, 1983-1986 (1994).
62. Sklair-Tavron, L. et al. Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. Proc. Natl Acad. Sci. USA 93, 11202-11207 (1996).
63. Robinson, T. E. & Kolb, B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J. Neurosci. 17, 8491-8497 (1997).
64. Robinson, T. E. & Kolb, B. Alterations in the morphology of dendrites and dendritic spines in the nucleus accumbens and prefrontal cortex following repeated treatment with amphetamine or cocaine. Eur. J. Neurosci. 11, 1598-1604 (2000).
65. Eisch, A. J., Barrot, M., Schad, C. A., Self, D. W. & Nestler E. J. Opiates inhibit neurogenesis in the adult rat hippocampus. Proc. Natl Acad. Sci. USA 97, 7579-7584 (2000).
66. Gage, F. H. Mammalian neural stem cells. Science 287, 1433-1438 (2000).
67. Fuchs, E. & Gould, E. Mini-review: in vivo neurogenesis in the adult brain: regulation and functional implications. Eur. J. Neurosci. 12, 2211-2214 (2000).
68. Horger, B. A. et al. Enhancement of locomotor activity and conditioned reward to cocaine by brain-derived neurotrophic factor. J. Neurosci. 19, 4110-4122 (1999).
69. Pierce, R. C., Pierce-Bancroft, A. F. & Prasad, B. M. Neurotrophin-3 contributes to the initiation of behavioral sensitization to cocaine by activating the Ras/Mitogen- activated protein kinase signal transduction cascade. J. Neurosci. 19, 8685-8695 (1999).
70. Messer, C. J. et al. Role of GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron 26, 247-257 (2000).
71. Wolf, D. H., Numan, S., Nestler, E. J. & Russell, D. S. Regulation of phospholipase Cy in the mesolimbic dopamine system by chronic morphine administration. J. Neurochem. 73, 1520-1528 (1999).
72. Berhow, M. T., Hiroi, N. & Nestler, E. J. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J. Neurosci. 16, 4707-4715 (1996).
73. Flores, C., Rodaros, D. & Stewart, J. Long-lasting induction of astrocytic basic fibroblast growth factor by repeated injections of amphetamine: blockade by concurrent treatment with a glutamate antagonist. J. Neurosci. 18. 9547-9555 (1998).
74. Bibb, J. A. et al. Cdk5 regulates action of chronic cocaine. Nature (in the press).
75. Chen, J. S. et al. Induction of cyclin-dependent kinase 5 in hippocampus by chronic electroconvulsive seizures: Role of AFosB. J. Neurosci. 20, 8965-8971 (2000).
76. Martin, K. C. & Kandel, E. R. Cell adhesion molecules, CREB, and the formation of new synaptic connections. Neuron 17, 567-570 (1996).
77. Silva, A. J. & Murphy, G. G. cAMP and memory: a seminal lesson from Drosophila and Aplysia. Brain Res. Bull. 50. 441-442 (1999).
78. Deisseroth, K., Bito, H., Schulman, H. & Tsien, R. W. Synaptic plasticity: A molecular mechanism for metaplasticity. Curr. Biol. 5, 1334-1338 (1995).
79. Yin, J. C. & Tully, T. CREB and the formation of long-term memory. Curr. Opin. Neurobiol. 6, 264-268 (1996).
80. Schuman, E. M. Neurotrophin regulation of synaptic transmission. Curr. Opin. Neurobiol. 9, 105-109 (1999).
81. Korte, M., Staiger, V., Griesbeck, O., Thoenen, H. & Bonhoeffer, T. The involvement of brain-derived neurotrophic factor in hippocampal long-term potentiation revealed by gene targeting experiments. J. Physiol. (Paris) 90, 157-164 (1996).
82. Luscher, C., Nicoll, R. A., Malenka, R. C., & Muller, D. Synaptic plasticity and dynamic modulation of the postsynaptic membrane. Nature Neurosci. 3, 545-550 (2000).
83. Nicola, S. M., Surmeier, J. & Malenka, R. C. Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens. Annu. Rev. Neurosci. 23, 185-215 (2000).
84. Jones, S., Kornblum, J. L. & Kauer, J. A. Amphetamine blocks long-term synaptic depression in the ventral tegmental area. J. Neurosci. 20, 5575-5580 (2000).
85. Thomas, M. J., Malenka, R. C. & Bonci, A. Modulation of long-term depression by dopamine in the mesolimbic system. J. Neurosci. 20, 5581-5586 (2000).
86. Malinow, R., Mainen, Z. F., & Hayashi, Y. LTP mechanisms: from silence to four-lane traffic. Curr. Opin. Neurobiol. 10, 352-357 (2000).
87. Scannevin, R. H. & Huganir, R. L. Postsynaptic organization and regulation of excitatory synapses. Nature Rev. Neurosci. 1, 133-141 (2000).
88. Carlezon, W. A. Jr et al. Sensitization to morphine induced by viral-mediated gene transfer. Science 277, 812-814 (1997).
89. Wolf, M. E. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog. Neurobiol. 54, 679-720 (1998).
90. Bell, K., Duffy, P. & Kalivas, P. W. Context-specific enhancement of glutamate transmission by cocaine. Neuropsychopharmacology 23, 335-344 (2000).
91. Li, Y. et al. Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations. Synapse 34, 169-180 (1999).